» Articles » PMID: 38776318

Comparison of 2D and 3D Oxygen-enhanced MRI of the Placenta

Overview
Journal PLoS One
Date 2024 May 22
PMID 38776318
Authors
Affiliations
Soon will be listed here.
Abstract

Oxygen-Enhanced Magnetic Resonance Imaging (OE-MRI) of the human placenta is potentially a sensitive marker of in vivo oxygenation. This methodological study shows that full coverage of the placenta is possible using 3D mapping of the change in longitudinal relaxation rate (ΔR1), in a group of healthy pregnant subjects breathing elevated levels of oxygen. Twelve pregnant subjects underwent a comparison of 2D and 3D OE-MRI. ΔR1 was mapped for a single 2D slice (ss-2D), a single matched-slice from the 3D volume (ss-3D) and the full 3D volume (vol-3D). The group-average median ΔR1 values for ss-3D (0.023 s-1) and vol-3D (0.022 s-1) do not differ significantly from ss-2D (0.020 s-1), when compared using a two-tailed paired t-test (ss-3D (p = 0.58) and vol-3D (p = 0.70)). However, median baseline T1 (T1b) for ss-2D was higher (1603 ms) than T1b for ss-3D (1540 ms, p = 0.07) and significantly higher than vol-3D (1515 ms, p = 0.02), when compared using a two-tailed paired t-test. In contrast with previous studies, no correlation of median ΔR1 with gestation age at scan for the normal group (N = 10) was observed for ss-2D, likely due to the smaller gestational range. Full volume OE-MRI maps reveal sensitivity to changes in ΔR1, with some participants showing an enhanced gradient in the intermediate space between the fetal and maternal sides of the placenta in the 3D data. This study shows that it is feasible to acquire whole placental volume OE-MRI data in women with healthy pregnancy.

References
1.
Pallotto E, Kilbride H . Perinatal outcome and later implications of intrauterine growth restriction. Clin Obstet Gynecol. 2006; 49(2):257-69. DOI: 10.1097/00003081-200606000-00008. View

2.
Gardosi J . Customized fetal growth standards: rationale and clinical application. Semin Perinatol. 2004; 28(1):33-40. DOI: 10.1053/j.semperi.2003.12.002. View

3.
Figueras F, Gratacos E . Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014; 36(2):86-98. DOI: 10.1159/000357592. View

4.
Ingram E, Hawkins L, Morris D, Myers J, Sibley C, Johnstone E . R1 changes in the human placenta at 3 T in response to a maternal oxygen challenge protocol. Placenta. 2016; 39:151-3. DOI: 10.1016/j.placenta.2016.01.016. View

5.
Wright C, Morris D, Baker P, Crocker I, Gowland P, Parker G . Magnetic resonance imaging relaxation time measurements of the placenta at 1.5 T. Placenta. 2011; 32(12):1010-5. PMC: 3588143. DOI: 10.1016/j.placenta.2011.07.008. View